1. Heaton J, Britten N, Krska J, Reeve J. Person-centred medicines optimisation policy in England: An agenda for research on polypharmacy. Prim Health Care Res Dev. 2017;18(1):24–34. https://doi.org/10.1017/S1463423616000207.
2. Duerden, M., Avery,T., Payne, R. 2013: Polypharmacy and medicines optimisation. Kingsfund. Available at https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf (Accessed Oct 2022)
3. Clyne, W., Blenkinsopp, A., Seaal R. 2008: A guide to medication review. Keele University, NPC Plus and Medicines Partnership. Available at agtmr_web.pdf (sefap.org) (Accessed Oct 2022)
4. NICE. 2015: Medicines Optimisation: the safe and effective use of medicines to enable the best possible outcomes. Available at https://www.nice.org.uk/guidance/ng5 (Accessed Oct 2022)
5. National Institute for Health and Care Excellence. Quality and Outcomes Framework indictor. Quality and Outcomes Framework Indicators | Standards & Indicators | NICE (Accessed Oct 2022)